Am J Transplant, Volume 18, Suppl 3 Archives - Page 187 of 211 - ATC Abstracts

2018 American Transplant Congress
De Nove Malignancies after Liver Transplantation: Single Center Experience in Korea
Y. Yoon,¹ J. Lee,¹ Y. You,² D. Kim.²
¹Surgery, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon, Republic of Korea; ²Surgery, Seoul St.Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
IntroductionDe novo malignancies are one of the leading causes of late mortality after liver transplantation (LT). We analyze the clinical characteristics, prevalence, risk factors, prevention…
2018 American Transplant Congress
Contemporary Practice Patterns & Outcomes after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Placement: A Multicenter US Experience of 1,146 Patients
J. Boike,¹ J. Ge,⁵ M. German,³ N. Jest,² G. Morelli,² E. Spengler,³ A. Said,³ A. Lee,³ A. Hristov,³ K. Kolli,⁴ J. Lai,⁴ A. Desai,⁵ S. Junna,⁵ B. Pokhrel,⁵ T. Couri,⁶ S. Paul,⁶ N. Christian-Miller,⁷ C. Frenette,⁷ M. Laurito,⁸ E. Verna,⁸ U. Rahim,⁹ A. Goel,⁹ A. Das,¹ S. Pine,¹ D. Gregory,¹ L. VanWagner.¹
¹Gastro & Hep, Northwestern, Chicago; ²Gastro & Hep, Univ of Florida, Gainesville; ³Gastro & Hep, Univ of Wisconsin, Madison; ⁴Med, Gastro & Hep, Radiology, UCSF, San Francisco; ⁵Med, Gastro & Hep, Univ of Arizona, Tucson; ⁶Med, Gastro & Hep, Univ of Chicago, Chicago; ⁷Gastro & Hep, Scripps Clinic, La Jolla; ⁸Gastro & Hep, Columbia, New York; ⁹Gastro & Hep, Stanford, Palo Alto.
Background: TIPS is effective for treating complications of portal hypertension. Historic, single center data suggest poor outcomes for MELD scores >15. We assessed contemporary outcomes…
2018 American Transplant Congress
Real-Time Expert Evaluation of Liver Biopsy for Transplant: The Significance of Smartphone and Microscope Adapter in Telepathology
N. Bath,¹ X. Wang,² J. Bledsoe,² M. Thijssen,¹ A. Ahearn,¹ B. Movahedi,¹ A. Bozorgzadeh,¹ P. Martins.¹
¹Surgery, University of Massachusetts, Worcester, MA; ²Pathology, University of Massachusetts, Worcester, MA.
Introduction: Liver biopsy at the time of procurement plays a crucial role in the acceptance of marginal grafts. Local pathologists and transplant surgery fellows are…
2018 American Transplant Congress
Racial Disparities in Post-Liver Transplant Survival before and after Share 35 Implementation
K. Ross,¹ R. Lynch,² R. Patzer.^1,2
¹Department of Epidemiology, Rollins School of Public Health, Atlanta, GA; ²Emory Transplant Center, Atlanta, GA.
Background: The Share 35 policy was intended to improve equity in access to liver transplantation by broadening regional sharing of livers for the sickest patients…
2018 American Transplant Congress
Living Donor Renal Transplantation in Adult Renal Transplant Recipients Varies Markedly across UNOS Networks
A. Brar,¹ A. Gruessner,¹ M. Salifu,¹ R. Gruessner,² N. Sumrani,² D. John,² F. Tedla.¹
¹Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY; ²Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY.
Background: Outcome after living donor kidney transplantation (LD) is significantly better than after deceased donor transplantation (DD). Disparities in access to living donor renal transplantation…
2018 American Transplant Congress
Identifying Patients at Risk of Mortality and Major Adverse Cardiovascular Events Following Simultaneous Pancreas and Kidney Transplantation Using the Pre-Transplant QRISK2 Score
P. Yiannoullou,^1,2 S. Goh,² H. Khambalia,^1,2 Z. Moinuddin,^1,2 A. Summers,^1,2 I. Shapey,^1,2 C. Fullwood,² T. Augustine,^1,2 M. Rutter,^1,2 D. van Dellen.^1,2
¹Transplant, Manchester University Foundation NHS Trust, Manchester, United Kingdom; ²University of Manchester, Manchester, United Kingdom.
Introduction Patients with type 1 diabetes mellitus and renal failure have increased mortality risk. Simultaneous Pancreas and Kidney transplantation (SPKT) provides survival benefit, but premature…
2018 American Transplant Congress
Impact of a Steroid Free Immunosuppressive Regimen on Patient and Graft Outcomes in Pancreas Transplant Recipients
M. Cote,¹ C. Rogers,¹ K. Khwaja,² A. Evenson,² M. Pavlakis,² K. Richards.¹
¹Pharmacy, Beth Israel Deaconess Medical Center, Boston, MA; ²Transplant Institute, Beth Israel Deaconess Medical Center, Boston, MA.
Steroids have been an important component of maintenance immunosuppression in solid organ transplant, but their adverse effect profile has led to the development of steroid…
2018 American Transplant Congress
Pregnancies in Female Pancreas Transplant Alone Recipients
P. Patel,¹ D. Kliniewski,² L. Coscia,² D. Armenti,² S. Constantinescu,^2,3 M. Moritz.^1,2,4
¹Surgery, Lehigh Valley Health Network, Allentown, PA; ²Transplant Pregnancy Registry International, Gift of Life Institute, Philadelphia; ³Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA; ⁴Surgery, Morsani College of Medicine, Tampa, FL.
This is the first series report of pregnancies after pancreas transplant alone (PTA). Data were collected by the Transplant Pregnancy Registry International (TPR) via questionnaires,…
2018 American Transplant Congress
Telemedicine Implementation in Organ Transplantation at a Metropolitan Academic Medical Center
D. Tsapepas, H. Li, D. Kohlberg, B. Watts, J. Monteiro, A. Monteiro, N. Jandovitz.
Columbia University / NewYork-Presbyterian Hospital, New York.
Transplant patients represent a complex patient population for which telemedicine may enhance patient access to the healthcare team, patient engagement, patient satisfaction and improved outcomes…
2018 American Transplant Congress
A Novel Conditioning Approach to Establish Chimerism Using Manipulation of JAK-STAT Pathways
H. Xu, A. Merchak, L. Kahn, A. Chhabra, Y. Wen, Y. Huang, S. Ildstad.
Institute for Cellular Therapeutics, University of Louisville, Louisville, KY.
Hematopoietic chimerism establishes donor-specific tolerance to solid organ allografts. Targeting recipient immune cells (T, NK cells and macrophages) can effectively reduce the dose of total…